Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

Rhea-AI Summary

Artivion, Inc. to present at Gilmartin Group Emerging Growth Company Showcase on September 21, 2023.

Positive

• Opportunity to showcase company's products and expertise

Negative

• None.

ATLANTA, Sept. 14, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Gilmartin Group Emerging Growth Company Showcase on Thursday, September 21, 2023.  The Company's presentation is scheduled to begin at 11:00 a.m. ET.

A live webcast of the presentation will be accessible through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Artivion          D. Ashley Lee                                                 Executive Vice President & Chief Financial Officer Phone: 770-419-3355	Gilmartin Group LLC Brian Johnston / Lynn Lewis Phone:  332-895-3222 investors@artivion.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-present-at-the-gilmartin-group-emerging-growth-company-showcase-301927523.html

SOURCE Artivion, Inc.